Literature DB >> 11150307

Transcriptional regulation of the mouse uncoupling protein-2 gene. Double E-box motif is required for peroxisome proliferator-activated receptor-gamma-dependent activation.

A V Medvedev1, S K Snedden, S Raimbault, D Ricquier, S Collins.   

Abstract

Uncoupling protein-2 (UCP2) is present in many tissues with relevance to fuel metabolism, and its expression is increased in fat and muscle in response to elevated circulating free fatty acids resulting from fasting and high fat feeding. We proposed a role for peroxisome proliferator-activated receptor-gamma (PPARgamma) as a mediator of these physiological changes in UCP2, because thiazolidinediones also increase expression of UCP2 in these cell types (). To determine the molecular basis for this regulation, we isolated the 7.3-kilobase promoter region of the mouse UCP2 gene. The -7.3-kilobase/+12-base pair fragment activates transcription of a reporter gene by 50-100-fold. Deletion and point mutation analysis, coupled with gel shift assays, indicate the presence of a 43-base pair enhancer (-86/-44) that is responsible for the majority of both basal and PPARgamma-dependent transcriptional activity. The distal (-86/-76) part of the enhancer specifically binds Sp1, Sp2, and Sp3 and is indistinguishable from a consensus Sp1 element in competition experiments. Point mutation in this sequence reduces basal activity by 75%. A second region (-74/-66) is identical to the sterol response element consensus and specifically binds ADD1/SREBP1. However, deletion of this sequence does not affect basal transcriptional activity or the response to PPARgamma. The proximal portion of the enhancer contains a direct repeat of two E-Box motifs, which contributes most strongly to basal and PPARgamma-dependent transcription of the UCP2 promoter. Deletion of this region results in a 10-20-fold reduction of transcriptional activity and complete loss of PPARgamma responsiveness. Point mutations in either E-Box, but not in the spacer region between them, eliminate the stimulatory response to PPARgamma. However, gel shift assays show that PPARgamma does not bind to this region. Taken together, these data indicate that PPARgamma activates the UCP2 gene indirectly by altering the activity or expression of other transcription factors that bind to the UCP2 promoter.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11150307     DOI: 10.1074/jbc.M010587200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  26 in total

Review 1.  Glucolipotoxicity: fuel excess and beta-cell dysfunction.

Authors:  Vincent Poitout; R Paul Robertson
Journal:  Endocr Rev       Date:  2007-11-29       Impact factor: 19.871

Review 2.  UCP2, a mitochondrial protein regulated at multiple levels.

Authors:  Massimo Donadelli; Ilaria Dando; Claudia Fiorini; Marta Palmieri
Journal:  Cell Mol Life Sci       Date:  2013-06-27       Impact factor: 9.261

3.  A novel intronic peroxisome proliferator-activated receptor gamma enhancer in the uncoupling protein (UCP) 3 gene as a regulator of both UCP2 and -3 expression in adipocytes.

Authors:  Anne Bugge; Majken Siersbaek; Maria S Madsen; Anita Göndör; Carole Rougier; Susanne Mandrup
Journal:  J Biol Chem       Date:  2010-04-01       Impact factor: 5.157

4.  The role of uncoupling protein 2 in macrophages and its impact on obesity-induced adipose tissue inflammation and insulin resistance.

Authors:  Xanthe A M H van Dierendonck; Tiphaine Sancerni; Marie-Clotilde Alves-Guerra; Rinke Stienstra
Journal:  J Biol Chem       Date:  2020-10-13       Impact factor: 5.157

Review 5.  Mitochondrial Uncoupling Proteins: Subtle Regulators of Cellular Redox Signaling.

Authors:  Petr Ježek; Blanka Holendová; Keith D Garlid; Martin Jabůrek
Journal:  Antioxid Redox Signal       Date:  2018-03-14       Impact factor: 8.401

6.  Uncoupling protein-2 up-regulation and enhanced cyanide toxicity are mediated by PPARalpha activation and oxidative stress.

Authors:  X Zhang; L Li; K Prabhakaran; L Zhang; H B Leavesley; J L Borowitz; G E Isom
Journal:  Toxicol Appl Pharmacol       Date:  2007-05-18       Impact factor: 4.219

7.  Hypertension and abnormal fat distribution but not insulin resistance in mice with P465L PPARgamma.

Authors:  Yau-Sheng Tsai; Hyo-Jeong Kim; Nobuyuki Takahashi; Hyung-Suk Kim; John R Hagaman; Jason K Kim; Nobuyo Maeda
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

8.  Rosiglitazone treatment reduces diabetic neuropathy in streptozotocin-treated DBA/2J mice.

Authors:  Timothy D Wiggin; Matthias Kretzler; Subramaniam Pennathur; Kelli A Sullivan; Frank C Brosius; Eva L Feldman
Journal:  Endocrinology       Date:  2008-06-26       Impact factor: 4.736

9.  Effects of UCP2 -866 G/A and ADRB3 Trp64Arg on rosiglitazone response in Chinese patients with Type 2 diabetes.

Authors:  Min Yang; Qiong Huang; Jing Wu; Ji-Ye Yin; Hong Sun; Hai-Ling Liu; Hong-Hao Zhou; Zhao-Qian Liu
Journal:  Br J Clin Pharmacol       Date:  2009-07       Impact factor: 4.335

Review 10.  ROS signaling, oxidative stress and Nrf2 in pancreatic beta-cell function.

Authors:  Jingbo Pi; Qiang Zhang; Jingqi Fu; Courtney G Woods; Yongyong Hou; Barbara E Corkey; Sheila Collins; Melvin E Andersen
Journal:  Toxicol Appl Pharmacol       Date:  2009-06-06       Impact factor: 4.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.